Supplementary Tables Indirect Treatment Comparisons of Avapritinib versus Midostaurin for Patients with Advanced Systemic Mastocytosis

<b>Table A: Inclusion and exclusion criteria for the clinical systematic literature review</b> <b>Table B: Summary of inclusion/exclusion of studies for ITCs</b> <b>Table C: Comparison of C-findings at baseline</b> <b>Table D: Baseline characteristics across studies – safety population and FAS</b> <b>Table E: Overall survival results</b> <b>Table</b><b> F: Overall response rate results</b> <b>Table</b><b> G: Complete remission results</b><b></b> <b>Table H: Summary of overall response rates and complete remission rates by the IWG-MRT-ECNM response criteria</b> <b></b>表A：临床系统综述的纳入与排除标准 表B：针对ITCs的研究纳入与排除情况汇总 表C：基线C类观测结果比较 表D：各项研究的基线特征——安全性人群与全分析集（FAS） 表E：总生存期结果 表F：总体缓解率结果 表G：完全缓解结果 表H：基于IWG-MRT-ECNM疗效判定标准的总体缓解率与完全缓解率汇总